Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Nov 13, 2021 (Letter of inquiry)

Later deadlines: Dec 13, 2021 (Full proposal)

Grant amount: Unspecified amount in in-kind support

Fields of work: Reproductive Health

Applicant type: Government Entity, Indigenous Group, Nonprofit, Faculty, Doctor, Research Scientist

Funding uses: Non-clinical Biomedical

Location of project: Anywhere in the world

Location of residency: Anywhere in the world


The NICHD has a state-of-the-art Chemical Synthesis and Optimization Facility for advancing male and/or female non-hormonal contraception developmentwith the capabilities and capacity for preclinical services including Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies (e.g., protein generation, high throughput screening, structure activity relationships, hit-to-lead generation, drug metabolism, fertility studies). The purpose of this FOA is to provide investigators with a mechanism to request services from this facility that would advance their development program for either male or female contraceptives.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed April 30, 2019 and last updated April 30, 2019